Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the prospective PETAML trial.
Stölzel F, Lüer T, Löck S, Parmentier S, Kuithan F, Kramer M, Alakel NS, Sockel K, Taube F, Middeke JM, Schetelig J, Röllig C, Paulus T, Kotzerke J, Ehninger G, Bornhäuser M, Schaich M, Zoephel K. Stölzel F, et al. Among authors: kotzerke j. Haematologica. 2020 Jun;105(6):1552-1558. doi: 10.3324/haematol.2019.223032. Epub 2019 Aug 29. Haematologica. 2020. PMID: 31467130 Free PMC article.
Reduced-Intensity Conditioning Combined with (188)Rhenium Radioimmunotherapy before Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia: The Role of In Vivo T Cell Depletion.
Schneider S, Strumpf A, Schetelig J, Wunderlich G, Ehninger G, Kotzerke J, Bornhäuser M. Schneider S, et al. Among authors: kotzerke j. Biol Blood Marrow Transplant. 2015 Oct;21(10):1754-60. doi: 10.1016/j.bbmt.2015.05.012. Epub 2015 May 19. Biol Blood Marrow Transplant. 2015. PMID: 26001695 Free article. Clinical Trial.
188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
Lauter A, Strumpf A, Platzbecker U, Schetelig J, Wermke M, Radke J, Kiani A, Wunderlich G, Thiede C, Ehninger G, Kotzerke J, Bornhäuser M. Lauter A, et al. Among authors: kotzerke j. Br J Haematol. 2010 Mar;148(6):910-7. doi: 10.1111/j.1365-2141.2009.08025.x. Epub 2009 Dec 7. Br J Haematol. 2010. PMID: 19995390 Free article. Clinical Trial.
Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy.
Zschaeck S, Hofheinz F, Zöphel K, Bütof R, Jentsch C, Schmollack J, Löck S, Kotzerke J, Baretton G, Weitz J, Baumann M, Krause M. Zschaeck S, et al. Among authors: kotzerke j. Eur J Nucl Med Mol Imaging. 2017 Oct;44(11):1813-1822. doi: 10.1007/s00259-017-3742-0. Epub 2017 Jun 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28600646
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging.
Löck S, Perrin R, Seidlitz A, Bandurska-Luque A, Zschaeck S, Zöphel K, Krause M, Steinbach J, Kotzerke J, Zips D, Troost EGC, Baumann M. Löck S, et al. Among authors: kotzerke j. Radiother Oncol. 2017 Sep;124(3):533-540. doi: 10.1016/j.radonc.2017.08.010. Epub 2017 Aug 23. Radiother Oncol. 2017. PMID: 28843726
Final Results of the Prospective Biomarker Trial PETra: [11C]-MET-Accumulation in Postoperative PET/MRI Predicts Outcome after Radiochemotherapy in Glioblastoma.
Seidlitz A, Beuthien-Baumann B, Löck S, Jentsch C, Platzek I, Zöphel K, Linge A, Kotzerke J, Petr J, van den Hoff J, Steinbach J, Krex D, Schmitz-Schackert G, Falk M, Baumann M, Krause M. Seidlitz A, et al. Among authors: kotzerke j. Clin Cancer Res. 2021 Mar 1;27(5):1351-1360. doi: 10.1158/1078-0432.CCR-20-1775. Epub 2020 Dec 29. Clin Cancer Res. 2021. PMID: 33376095
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy.
Zschaeck S, Löck S, Leger S, Haase R, Bandurska-Luque A, Appold S, Kotzerke J, Zips D, Richter C, Gudziol V, Schreiber A, Zöphel K, Baumann M, Krause M. Zschaeck S, et al. Among authors: kotzerke j. Radiother Oncol. 2017 Mar;122(3):437-444. doi: 10.1016/j.radonc.2017.01.019. Epub 2017 Feb 17. Radiother Oncol. 2017. PMID: 28222892
385 results